Dr. Rath Health Foundation

Dr. Rath Health Foundation

Responsibility for a healthy world Dr. Rath Research Institute 100+ Studies Published In PubMed


Click here to open as a PDF

Dr. Rath identified a common pathomechanism of all cancers, which is the degradation of the surrounding connective tissue, as a precondition for cancer metastasis. He suggested that the amino acid lysine and vitamin C could effectively control this process.

Cancer develops when cells in one part of the body begin to grow out of control. Normal body cells grow, divide, and die in a systematic way. During the early years of a person’s life, normal cells divide more rapidly until the person becomes an adult. After that, cells in most parts of the body divide only to replace worn out or dying cells and to repair injuries. In the case of cancer cells, the genetic program that regulates their growth cycle is interrupted, causing the cells to become immortal and constantly divide. Cancer cell growth never stops, and it results in the formation of a tumor mass.

To stop cancer metastasis, the activity of MMPs must be inhibited. Dr. Rath and his team of researchers at the Dr. Rath Research Institute have identified a specific combination of nutrients that can inhibit the activity of MMPs and stop the spread of cancer cells. Further research has led to the development of a nutrient combination, including vitamin C, the amino acids L-lysine and L-proline and a green tea extract known as Epigallocatechin Gallate (EGCG), that works synergistically to stop the spread of cancer cells through connective tissue.

Dr. Rath's Research Confirmed

USA, September 13, 2005. Dr. Mark Levine of the US National Institutes of Health today reported findings that vitamin C may fight cancer in high IV doses. In five out of nine cancer cells line exposed to the ascorbate form of vitamin C there was a 50% decrease in survival of the cancerous cells. The study concluded that these results can influence future drug development. The results also confirm Dr. Rath's findings published in 2002 regarding the role of vitamin C in slowing down tumour growth, immobilizing cancer cells and preventing their spread.
Read an abstract of the NIH study in the Proceedings of the National Academy of Sciences.

Research done at Copenhagen University which has been published in the International Journal of Cancer also confirmed Dr. Rath's research. The Danish study found that the lack of the enzyme urokinase plasminogen activator (uPA) can stop the spread of cancer, as shown in mice genetically modified to not have the enzyme. The absence of uPA prevents the ability of cancer cells to dissolve collagen and metastasize to other parts of the body, but today there are no pharmaceutical solutions to block uPA.
Read the study online (External link)

Worldwide Studies and Reports